Related Experiment Video
Updated: Feb 8, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Frequent epigenetic alterations in polycomb repressive complex 2 in osteosarcoma cell lines
Helin Feng1, Heather Tillman2, Gang Wu3
1Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, People's Republic of China.
Abstract:
Osteosarcoma (OS) cell lines are widely used in understanding the biological functions of cancer, identification and validation of therapeutic targets, as well as in vitro or in vivo preclinical drug screening. Here we report there is a frequent loss-of-function of polycomb repressive complex 2 (PRC2) in OS cell lines but it is rare in tumor samples based on genomic sequencing data, western blotting and immunohistochemistry analysis of H3K27me3. U2OS and 143B cell lines have a complete loss of function of PRC2 and several others have partial loss. In OS tumor tissues, only 1 out of 14 has low expression of H3K27me3. Kaplan-Meier analysis indicates that high EZH2, the component of PRC2, is associated with poor metastasis-free survival. Our observations are to raise the alarm that particular caution should be taken when using OS cell line models to study the disease, functional genomics, therapeutic target validation, drug screening, and epigenetic studies. Nevertheless, these cell lines will become useful biological tools to dissect the functions of PRC2.
Insights
Osteosarcoma cell lines frequently lack polycomb repressive complex 2 (PRC2) function, unlike tumor samples. This finding necessitates caution when using these cell lines for cancer research and drug screening.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Osteosarcoma (OS) cell lines are crucial for cancer research, target identification, and drug screening.
- Understanding the epigenetic landscape of OS is vital for developing effective therapies.
Purpose of the Study:
- To investigate the functional status of polycomb repressive complex 2 (PRC2) in osteosarcoma cell lines compared to tumor samples.
- To assess the clinical relevance of PRC2 components, such as EZH2, in osteosarcoma patient survival.
Main Methods:
- Genomic sequencing, Western blotting, and immunohistochemistry were used to analyze PRC2 function and H3K27me3 levels.
- Kaplan-Meier analysis was performed to correlate EZH2 expression with metastasis-free survival in OS patients.
Main Results:
- A frequent loss-of-function of PRC2 was observed in osteosarcoma cell lines, with U2OS and 143B showing complete loss.
- In contrast, PRC2 dysfunction was rare in osteosarcoma tumor tissues, with only one sample showing low H3K27me3 expression.
- High EZH2 expression was significantly associated with poor metastasis-free survival in osteosarcoma patients.
Conclusions:
- Osteosarcoma cell lines exhibit frequent PRC2 loss-of-function, differing significantly from tumor samples.
- Caution is advised when utilizing these cell lines for studying OS biology, target validation, and drug screening.
- Despite limitations, these cell lines can serve as valuable tools for dissecting PRC2 functions in cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Cell Lines
Repressed Memory
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...

